Modalis Therapeutics

Business Services · Massachusetts, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

43 Foundry Ave, Waltham, Massachusetts, ...

Phone Number

(617) 219-9808

Revenue

$20 Million

Industry

Business Services Research & Development

About Modalis Therapeutics

Modalis Therapeutics Corporation is a biotech company focused on developing treatments for genetic diseases using its proprietary genome editing platform, CRISPR-GNDM. The company specializes in epigenome editing technology that selectively targets and controls specific genes to treat diseases. Their innovative approach aims to restore the precise orchestration of protein production in the body, which is crucial for maintaining health. The intended clients include patients suffering from genetic disorders, as well as potential partners for collaborative development.Explore more
Modalis Therapeutics's Social MediaSIC Code 87,873NAICS Code 54,541Show more

Modalis Therapeutics Org Chart

PhoneEmail
YQ
United States flag for contact location.

Vice President, Neuromuscular Diseases

PhoneEmail
YN
United States flag for contact location.

Vice President (Executive Officer), Operation...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
TA
United States flag for contact location.

Senior Director - In Vivo Pharmacology

PhoneEmail
RM
United States flag for contact location.

Director, Immunology

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
Illustration of an envelope

Modalis Therapeutics Tech Stack

A closer look at the technologies used by Modalis Therapeutics

Top Business Services Companies

Frequently Asked Questions Regarding Modalis Therapeutics

What is Modalis Therapeutics's official website?
Modalis Therapeutics's official website is www.modalistx.com
What is Modalis Therapeutics's Revenue?
Modalis Therapeutics's revenue is $20 Million
What is Modalis Therapeutics's SIC code?
Modalis Therapeutics's SIC: 87,873
What is Modalis Therapeutics's NAICS code?
Modalis Therapeutics's NAICS: 54,541
How many employees does Modalis Therapeutics have?
Modalis Therapeutics has 11-50 employees
What industry does Modalis Therapeutics belong to?
Modalis Therapeutics is in the industry of: Business Services, Research & Development
What technology does Modalis Therapeutics use?
Some of the popular technologies that Modalis Therapeutics uses are: WordPress.org, PHP, Fujitsu Managed Hosting, Google Font API
How do I contact Modalis Therapeutics?
Modalis Therapeutics contact info: Phone number: (617) 219-9808 Website: www.modalistx.com
What does Modalis Therapeutics do?

Modalis Therapeutics Corporation is a biotech company focused on developing treatments for genetic diseases using its proprietary genome editing platform, CRISPR-GNDM. The company specializes in epigenome editing technology that selectively targets and controls specific genes to treat diseases. Their innovative approach aims to restore the precise... orchestration of protein production in the body, which is crucial for maintaining health. The intended clients include patients suffering from genetic disorders, as well as potential partners for collaborative development.Read More

What are Modalis Therapeutics social media links?
Modalis Therapeutics Linkedin page Modalis Therapeutics Twitter page Modalis Therapeutics Facebook page
Is Modalis Therapeutics a public company?
Modalis Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Modalis Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.